Ofichem buys site in Sweden

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which is known as OT Chemistry, to complemen its existing GMP manufacturing operations in Ter Apel. Terms were not disclosed. 

CEO and owner Dr Weite H. Oldenziel commented that Ofichem will use the site to support early-phase, IP-driven drug substance development and expand its non-GMP capabilities in the small molecule space. The site specialises in small-scale, early-phase development work in both traditional small molecules and emerging modalities such as ADCs, oligonucleotides and PROTACs.

“This acquisition is a strategic building block in Ofichem’s broader transformation,” said Oldenziel. “Our goal is to serve innovative biotech companies with agile, early-stage development solutions, and this site offers precisely the expertise and technologies we need to deliver on that vision.”